Aandeel BGMD BG MEDICINE, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen BG Medicine, Inc.

Aandelen

BGMD

US08861T2069

Vertraagde tijd OTC Markets
Andere beurzen
 16:36:41 06-12-2023 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,000001 USD -.--% Intraday-grafiek van BG Medicine, Inc. -.--% -.--%
2015 Transcript : BG Medicine, Inc. - Special Call
2015 Transcript : BG Medicine, Inc., Q2 2015 Earnings Call, Aug 19, 2015

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015
BG Medicine Announces Board Changes
BG Medicine Withdraws 510(K) Premarket Notification for Proposed Additional Indication for the Bgm Galectin-3® Test
BG Medicine, Inc. Amends License and Distribution Agreement for Galectin-3 with Abbott Laboratories
BG Medicine, Inc. Announces Board Changes
BG Medicine, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015
Certain Options of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Certain Warrants of BG Medicine, Inc. are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Certain shares of BG Medicine, Inc.'s Common Stock are subject to a Lock-Up Agreement Ending on 11-NOV-2015.
Timothy Harris Resigns to Board of Directors and Audit Committee of BG Medicine, Inc
BG Medicine, Inc.(OTCPK:BGMD) dropped from MSCI Acwi + Frontier Markets(acwi Fm) All Cap Index
BG Medicine, Inc.(OTCPK:BGMD) dropped from S&P TMI Index
BG Medicine, Inc.(OTCPK:BGMD) dropped from CRSP US Total Market Index
BG Medicine, Inc.(NasdaqCM:BGMD) dropped from NASDAQ Composite Index
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015
BG Medicine, Inc. Announces Payoff of Secured Term Loan
BG Medicine, Inc. announced that it has received $2.5 million in funding from Flagship Ventures.
BG Medicine, Inc. Announces First Automated Test for Galectin-3 Now Available in U.S
BGMD Seeks Acquisitions
BG Medicine, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Financial Guidance for 2015
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BGMD
  4. Nieuws BG Medicine, Inc.
  5. Andere talen